FEMISTRA ANASTROZOLE TABLET 1MG

Femistra Anastrozole Tablet 1mg is a prescription hormonal therapy designed for postmenopausal women with hormone receptor-positive breast cancer. This targeted treatment is highly effective in managing estrogen-dependent tumor growth and is commonly recommended by oncologists as part of a comprehensive breast cancer care plan.

Femistra Anastrozole Tablet 1 mg works by inhibiting the aromatase enzyme, which reduces estrogen production in the body. By lowering estrogen levels, it slows the growth of cancer cells that rely on this hormone, helping to control tumor progression and improve patient outcomes.

Administered orally as directed by oncologists, Femistra Anastrozole Tablet 1 mg is easy to incorporate into daily treatment schedules. Patients are advised to follow their oncologist’s instructions carefully, ensuring maximum effectiveness while monitoring for potential side effects under medical supervision.

Product Features

• Contains Anastrozole 1 mg
• Aromatase inhibitor for hormonal cancer therapy
• Used in hormone-positive breast cancer
• Reduces estrogen production
• Convenient oral tablet dosage
• Prescription-only oncology medicine

How It Helps

• Blocks estrogen production to slow tumor growth
• Targets hormone receptor-positive breast cancer cells
• Reduces the risk of cancer recurrence after surgery
• Supports long-term breast cancer management in postmenopausal women
• Easy-to-take oral tablet for convenient daily use